Negocie Gilead GILD

Gráfico Gilead ao vivo

Fundamentos do instrumento

Weekly Search
Weekly
Daily
Data Fechar Mudança Alteração (%): Abertura Max Min

Gilead news

Frances Wang 2024 Aug 04, 16:00

The Week Ahead: ISM services, SMCI

CFD Trading
Magnificent Seven earnings take centre stage in the markets this week
Neil Wilson 2024 Apr 19, 01:00

Week ahead: Wall Street’s Magnificent Seven earnings are up

Commodities Forex Indices Shares
Disney is catching up with Netflix
Neil Wilson 2024 Feb 01, 08:03

Week ahead: Earnings season climax

Forex Indices
Consumer inflation
Neil Wilson 2023 Nov 03, 04:01

Week ahead: RBA poised to hike?

Forex Indices
Megacap-tech-stocks.jpg
Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Últimas notícias

Mostrar mais
Sophia Claire 2025 Sep 04, 09:20

Foreign Exchange Markets' Risk Aversion Spikes Ahead of US Jobs Data

Ava Grace 2025 Sep 04, 08:20

Unlikely Alliance Emerges in Congress to Ban Stock Trading for Lawmakers

Ava Grace 2025 Sep 04, 07:20

UK Gilts: A Generational Buying Opportunity? Analyzing the Bond Market Surge

Ava Grace 2025 Sep 04, 06:20

Optimus Next Gen: A Glimpse at Tesla's New Gold Robot and Musk's Future Vision

Sophia Claire 2025 Sep 04, 06:20

European Nations Weigh Ukraine Security Pledges Amid Deployment Disagreements

Sophia Claire 2025 Sep 04, 05:20

EU-US Trade Agreement Revamp Threatens Fragile Truce, Sparks Concerns

Ava Grace 2025 Sep 04, 04:20

Gold and Silver Price Swings: Federal Reserve Rate Cut Expectations in Focus

Emma Rose 2025 Sep 04, 03:20

US Congress Standoff: Government Shutdown Looms Amid Blame Game

Info

Spread

0.70

Spread (%)

0.6219 %

Alavancagem

1:10

Juro overnight, Compra

-0.0597 %

Juro overnight, Venda

-0.0292 %

Moeda

USD

Horários de Negociação

Mercados fechados

Quinta-feira

13:31 - 19:59

Segunda-feira

13:31-19:59

Terça-feira

13:31-19:59

Quarta-feira

13:31-19:59

Sexta-feira

13:31-19:59

Análise e estatística

Abertura

---

Fechamento anterior

---

Alta/baixa em 52 semanas

--- – ---

Capitalização de mercado

139851694080

Ações em circulação

1240809984

Data dos rendimentos (Próxima)

2013-01-28

Rendim Divid

2025-09-29

Data Ex-Dividendos

2025-09-15

Taxa anual futura de dividendos

3.16

Rendimento anual futuro de dividendos

0.028

EPS

5.04

Saiba mais sobre este instrumento

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Instrumentos relacionados

Ativo
Venda
Comprar
Alteração (%):
Instrumentos relacionados

latest_education_articles

Mostrar mais
Trustpilot